High Frequency of Alternative Splicing Variants of the Oncogene Focal Adhesion Kinase in Neuroendocrine Tumors of the Pancreas and Breast

Newswise — Researchers from Chinese Academy of Medical Sciences and Peking Union Medical College, et al. have conducted a study entitled “High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast”. This study was published in Frontiers of Medicine, Volume 17, Issue 5.

The characteristic genetic abnormality of neuroendocrine neoplasms (NENs), a heterogeneous group of tumors found in various organs, remains to be identified. Based on the analysis of the splicing variants of an oncogene Focal Adhesion Kinase (FAK) in The Cancer Genome Atlas datasets that contain 9193 patients of 33 cancer subtypes, the study found that Box 6/Box 7-containing FAK variants (FAK6/7) were observed in 7 (87.5%) of 8 pancreatic neuroendocrine carcinomas and 20 (11.76%) of 170 pancreatic ductal adenocarcinomas (PDACs). The researchers tested FAK variants in 157 tumor samples collected from Chinese patients with pancreatic tumors, and found that FAK6/7 was positive in 34 (75.6%) of 45 pancreatic NENs, 19 (47.5%) of 40 pancreatic solid pseudopapillary neoplasms, and 2 (2.9%) of 69 PDACs. They further tested FAK splicing variants in breast neuroendocrine carcinoma (BrNECs), and found that FAK6/7 was positive in 14 (93.3%) of 15 BrNECs but 0 in 23 non-NEC breast cancers. They explored the underlying mechanisms and found that a splicing factor serine/arginine repetitive matrix protein 4 (SRRM4) was overexpressed in FAK6/7-positive pancreatic tumors and breast tumors, which promoted the formation of FAK6/7 in cells. These results suggested that FAK6/7 could be a biomarker of NENs and represent a potential therapeutic target for these orphan diseases.

This study was supported by the Key Project of the National Natural Science Foundation of China, the National Key Research and Development Program of China, the CAMS Innovation Fund for Medical Sciences, the CAMS Initiative for Innovative Medicine, and the National Natural Science Foundation of China. For more detailed information, the full paper is available at: https://journal.hep.com.cn/fmd/EN/10.1007/s11684-023-1009-7.


Continue Reading